Day: July 5, 2021

IQE plc Cardiff, UK5 July 2021 Issue of shares IQE plc (AIM:  IQE, “IQE” or the “Company”), the leading global supplier of advanced semiconductor wafer products and material solutions to the semiconductor industry, announces that it has agreed to issue 687,000 new ordinary shares of 1 pence each in the Company (“Ordinary Shares”) to a number of operational staff in South Wales. The decision to issue these Ordinary Shares was made in recognition of share options forfeited for operational reasons. Executive Directors and members of the Executive Management Board will not receive any Ordinary Shares as part of this issuance. The total number of voting rights in the Company following Admission will be 802,006,479. This figure may be used by shareholders as the denominator for the calculations by which they will determine...

Nasdaq CopenhagenLondon Stock ExchangeEuronext DublinOther stakeholders Date        05.07.2021 Share buy-back programme – week 26 The share buy-back programme runs from and including 4 February 2021 up to and including 30 July 2021. During this period Ringkjøbing Landbobank will buy-back shares to a maximum market value of DKK 255 million under a share buy-back programme, see company announcement of 3 February 2021. The programme is implemented in compliance with EU Commission Regulation No. 596/2014 of 16 April 2014 and EU Commission Delegated Regulation No. 2016/1052 of 8 March 2016, which together constitute the “Safe Harbour” regulation. The following transactions have been made under the programme:Date Number of shares Average purchase price (DKK) Total purchased under the programme (DKK)Total in accordance with the last...

Company Announcement No. 895 On 27 April 2021, we initiated a share buyback programme, as described in Company Announcement No. 883. According to the programme, the company will in the period from 27 April 2021 to 28 July 2021 purchase own shares up to a maximum value of DKK 4,000 million and no more than 4,000,000 shares, corresponding to 1.79% of the share capital at commencement of the programme. The programme has been implemented in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour rules.Trading day   Number of shares bought back   Average transaction price   Amount DKK               Accumulated trading for days 1-40 1,581,465   1,431.72   2,264,209,63741: 28 June 2021   75,000   1,484.49   111,336,75042: 29...

Finanstilsynet har d. 2. juli 2021 godkendt, at de afdelinger under Investeringsforeningen Nordea Invest, der ikke allerede har underliggende andelsklasser, opsplittes i andelsklasser.  De eksisterende afdelinger vil fortsætte som andelsklasse KL 1, og samtidig har Finanstilsynet givet tilladelse til oprettelse af nye andelsklasser – KL 2 – under samtlige investeringsforeningens afdelinger. Opsplitningen i og nyetableringen af andelsklasser forventes gennemført i oktober 2021. Med venlig hilsen Nordea Fund Management, filial af Nordea Funds Oy, Finland Tom Holflod Senior Product Manager

Press Release, July 5, 2021 Systemair AB (NASDAQ OMX Stockholm: SYSR) has acquired the remaining 50.1% of the shares in Burda WTG in Germany. BURDA WTG develops, produces and supplies infrared radiant heaters and heating panels and associated control equipment with several own patents. The head office is located in Eschborn, near Frankfurt / Main, Germany. Sales in 2020 amounted to approximately EUR 4 million. “Burda WTG is the market leader in infrared heaters for outdoor applications and a perfect complement to Frico’s product range. Burda also shares the same passion for creating smart solutions for energy-efficient heating of outdoor environments as Frico AB “, says Roland Kasper, CEO, Systemair. For further information contact: Roland Kasper, CEO, + 46 73 094 40 13Anders Ulff, CFO, + 46 70 577 40 09 Systemair AB, SE-739...

Press ReleaseNicox to Receive $2 Million from Ocumension Therapeutics as Advance Milestone Payment under ZERVIATE® AgreementJuly 5, 2021 – release at 7:30 am CET Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced that it has amended its March 2019 license agreement with Ocumension Therapeutics, under which Ocumension has exclusive rights to develop and commercialize ZERVIATE® (cetirizine ophthalmic solution), 0.24% in the Chinese and the majority of South East Asian markets. Under the amended agreement, Ocumension will immediately pay Nicox $2 million in full advance payment of the future development and regulatory milestones for the product. Amendments were made to certain rights under non-financial clauses of the agreement. Nicox remains eligible to...